发明申请
WO2019101789A1 RADIOIMMUNOCONJUGATES IN COMBINATION WITH OTHER DRUGS AS TREATMENT AGAINST NHL
审中-公开
基本信息:
- 专利标题： RADIOIMMUNOCONJUGATES IN COMBINATION WITH OTHER DRUGS AS TREATMENT AGAINST NHL
- 申请号：PCT/EP2018/082065 申请日：2018-11-21
- 公开(公告)号：WO2019101789A1 公开(公告)日：2019-05-31
- 发明人： POUGET, Jean Pierre , PICHARD, Alexandre , SYLJUÅSEN, Randi , RØDLAND, Gro Elise , HEYERDAHL, Helen , PATZKE, Sebastian , DAHLE, Jostein , REPETTO-LLAMAZARES, Ada , MALENGE, Marion Masita
- 申请人： NORDIC NANOVECTOR ASA
- 申请人地址： Kjelsåsveien 168B 0884 Oslo NO
- 专利权人： NORDIC NANOVECTOR ASA
- 当前专利权人： NORDIC NANOVECTOR ASA
- 当前专利权人地址： Kjelsåsveien 168B 0884 Oslo NO
- 代理机构： AERA A/S
- 优先权： EP17202982.9 20171122; EP18168529.8 20180420; EP18199873.3 20181011
- 主分类号： A61K51/10
- IPC分类号： A61K51/10 ; A61K31/166 ; A61K31/4184 ; A61K31/4196 ; A61K31/4535 ; A61K31/497 ; A61K31/502 ; A61K31/506 ; A61K31/519 ; A61K31/55 ; A61K31/5517 ; A61K31/635 ; A61K39/00 ; A61K45/06 ; C07K16/28 ; C07K16/30 ; A61P35/00
摘要：
The present invention relates to a combination of radioimmunoconjugates and a protein or molecule capable of leading to progression of the cell cycle through the G2/M checkpoint, a protein or molecule capable of inhibiting progression through Mitosis, a protein or molecule which is a BCL2 inhibitor, or a protein or molecule which is a PARP inhibitor, for use as a medicament. The medicament may be against Non-Hodgkin's lymphoma (NHL).
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61K | 医用、牙科用或梳妆用的配制品 |
| ------A61K51/00 | 用于治疗或体内测试用的含有放射性物质的配制品 |
| --------A61K51/02 | .以载体为特征 |
| ----------A61K51/04 | ..有机化合物 |
| ------------A61K51/08 | ...肽，例如蛋白质 |
| --------------A61K51/10 | ....抗体或免疫球蛋白；其片段 |